1. Home
  2. ARDX vs NEO Comparison

ARDX vs NEO Comparison

Compare ARDX & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$6.23

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$11.87

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARDX
NEO
Founded
2007
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
2014
1999

Fundamental Metrics

Financial Performance
Metric
ARDX
NEO
Price
$6.23
$11.87
Analyst Decision
Strong Buy
Buy
Analyst Count
10
10
Target Price
$10.65
$12.56
AVG Volume (30 Days)
2.7M
1.8M
Earning Date
10-30-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$398,234,000.00
$709,162,000.00
Revenue This Year
$22.71
$10.90
Revenue Next Year
$27.81
$9.88
P/E Ratio
N/A
N/A
Revenue Growth
58.12
10.10
52 Week Low
$3.21
$4.72
52 Week High
$6.78
$19.12

Technical Indicators

Market Signals
Indicator
ARDX
NEO
Relative Strength Index (RSI) 62.17 60.77
Support Level $5.77 $11.59
Resistance Level $6.20 $12.26
Average True Range (ATR) 0.27 0.42
MACD 0.03 -0.07
Stochastic Oscillator 91.30 49.80

Price Performance

Historical Comparison
ARDX
NEO

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: